Bifunctional compounds

The application discloses compounds useful in treatment of diabetes, weight loss and/or reduction of cardiovascular risks. The compounds are bi-functional and therefore suitable as a simple treatment for patients that may benefit from treatment with both a GLP-1 receptor agonist and a PCSK9 inhibito...

Full description

Saved in:
Bibliographic Details
Main Authors Reedtz-Runge, Steffen, Tornoee, Christian Wenzel, Lykke, Lennart, Kodal, Anne Louise Bank
Format Patent
LanguageEnglish
Published 23.07.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The application discloses compounds useful in treatment of diabetes, weight loss and/or reduction of cardiovascular risks. The compounds are bi-functional and therefore suitable as a simple treatment for patients that may benefit from treatment with both a GLP-1 receptor agonist and a PCSK9 inhibitor.
Bibliography:Application Number: US201816632007